Furosemide: Adverse Effects, Renal Function Monitoring, and Managing Electrolyte Imbalance in Loop Diuretic Therapy

Furosemide, a potent loop diuretic, is widely used in clinical practice for managing conditions such as heart failure, hypertension, and edema associated with renal diseases. However, its use is not without risks, and it is crucial for physicians to be aware of the potential adverse effects and strategies for monitoring renal function in patients receiving this medication.
Adverse Effects of Furosemide
Furosemide works by inhibiting sodium and chloride reabsorption in the loop of Henle, resulting in increased excretion of water and electrolytes. This mechanism can lead to electrolyte imbalance, including hyponatremia and hypokalemia, which are common complications in patients treated with loop diuretics. Additionally, hypovolemia poses a significant risk, especially in patients with pre-existing renal or cardiac insufficiency.
Another notable adverse effect is ototoxicity, which may present as tinnitus or hearing loss, particularly when high doses are administered or in combination with other ototoxic medications. Rapid intravenous administration can also increase this risk [1].
Renal function may deteriorate with the use of furosemide, particularly in patients with acute or chronic renal insufficiency. Studies have shown that combining furosemide with other diuretics, such as mannitol, does not offer significant advantages in preventing cisplatin-induced nephrotoxicity [2]. Furthermore, concomitant use of furosemide with medications like vancomycin may increase the risk of nephrotoxicity [3].
Recommendations for Monitoring Renal Function
Regular monitoring of renal function in patients receiving furosemide is essential. This includes measuring serum electrolytes and creatinine to detect any early renal deterioration. BOLD-MRI has emerged as a promising tool for assessing renal oxygenation and may be useful in the future for predicting declines in renal function [4].
In patients with heart failure, the combination of furosemide with other diuretics should be carefully considered and tailored to minimize the risk of adverse effects [5]. Additionally, magnesium supplementation may be beneficial in preventing nephrotoxicity in patients receiving cisplatin chemotherapy [2].
Conclusions
Furosemide remains a valuable tool in managing various medical conditions, but its use requires careful vigilance to avoid complications. Physicians must be alert to signs of electrolyte imbalance, hypovolemia, and ototoxicity, and adjust treatment as necessary to protect renal function. Implementing appropriate monitoring strategies is crucial for optimizing treatment outcomes and minimizing associated risks.
Referencias
- [1] Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial.
- [2] Comparison of preventive effects of combined furosemide and mannitol versus single diuretics, furosemide or mannitol, on cisplatin-induced nephrotoxicity.
- [3] Retrospective Analysis of Vancomycin Nephrotoxicity in Elderly Chinese Patients.
- [4] Blood Oxygenation Level-Dependent MRI to Assess Renal Oxygenation in Renal Diseases: Progresses and Challenges.
- [5] Assessing the Effectiveness and Safety of Combination Diuretic Therapy in Heart Failure: A Systematic Review and Meta-Analysis.
Created 6/1/2025